1.A.27 The Phospholemman (PLM) Family
The PLM family, a member of the Dysadherin or FXYD superfamily (Garty and Karlish 2006), includes mammalian phospholemmans of 8-10 kDa size. They span the membrane once with their N-termini outside. These proteins induce a hyperpolarization-activated chloride current in Xenopus oocytes. They are found in muscle and many body tissues and are targets of protein kinases A and C. Other possible members include the chloride-conductance inducer protein, Mat8, and Na+/K+-ATPase γ-subunit 'proteolipids.' These proteins are smaller, but of the same orientation in the membrane (see below).
PLM forms anion-selective channels when reconstituted in planar lipid bilayers. These channels display a linear current-voltage relationship, have a unitary conductance and are open most of the time at voltages between -70 and +70 mV. The PLM channel is permeable to both organic and inorganic anions including chloride, taurine, lactate, glutamate, isethionate, and gluconate. These channel proteins resemble cardiac γ-subunits of the Na+, K+-ATPase (FXYD) (TC #3.A.3).
Members of the FXYD family (FXYD1-12) regulate the Na+-K+-ATPase, phospholamban, sarcolipin, myoregulin, and DWORF, which regulate the sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) (Pirkmajer et al. 2017). FXYD5, a member of the FXYD family of single spanning type I membrane proteins (also called FXYD-containing ion transporter regulator 5) interacts with and regulates ion channels and the Na+,K+-ATPase (Lubarski et al., 2005). The same is true for at least 5 other FXYD proteins including FXYD1. These proteins are members of the dysadherin superfamily of ion channels and ion channel regulators (Lifshitz et al., 2006). The cytoplasmic tail of PLM interacts with the intracellular loop of the cardiac Na+/Ca2+ exchanger (Wang et al., 2006). PLM coordinately regulates the cardiac Na+/Ca2+ exchanger and the Na+,K+-ATPase (Cheung et al. 2013). For this reason, TC Family 1.A.27 could also be listed under subfamily 8.A.
A mutation in the human FXYD2 polypeptide (Na-K-ATPase gamma subunit) that changes a conserved transmembrane glycine to arginine is linked to dominant renal hypomagnesemia. Xenopus laevis oocytes injected with wild-type FXYD2 or the mutant G41R cRNAs expressed large nonselective ion currents. However, in contrast to the wild-type FXYD2 currents, inward rectifying cation currents were induced by hyperpolarization pulses in oocytes expressing the G41R mutant. Injection of EDTA into the oocyte removed inward rectification in the oocytes expressing the mutant, but did not alter the nonlinear current-voltage relationship of the wild-type FXYD2 pseudo-steady-state currents. Extracellular divalent ions, Ca2+ and Ba2+, and trivalent cations, La3+, blocked both the wild-type and mutant FXYD2 currents. Site-directed mutagenesis of G41 demonstrated that a positive charge at this site is required for the inward rectification. When the wild-type FXYD2 was expressed in Madin-Darby canine kidney cells, the cells in the presence of a large apical-to-basolateral Mg2+ gradient and at negative potentials had an increase in transepithelial current compared with cells expressing the G41R mutant or control transfected cells. Moreover, this current was inhibited by extracellular Ba2+ at the basolateral surface. These results suggest that FXYD2 can mediate basolateral extrusion of magnesium from cultured renal epithelial cells (Sha et al. 2008).
PLM is a 72-amino acid protein consisting of the signature PFXYD motif in the extracellular N terminus, a single transmembrane (TM) domain, and a C-terminal cytoplasmic tail containing three phosphorylation sites. In the heart, PLM co-localizes and co-immunoprecipitates with the Na+-K+-ATPase, the Na+/Ca2+ exchanger, and L-type Ca2+ channel. The TM domain of PLM interacts with TM9 of the α-subunit of Na+-K+-ATPase, while its cytoplasmic tail interacts with two small regions (spanning residues 248-252 and 300-304) of the proximal intracellular loop of the Na+/Ca2+ exchanger. Under stress, catecholamine stimulation phosphorylates PLM at serine(68), resulting in relief of inhibition of the Na+-K+-ATPase by decreasing the Km for Na+ and increasing the Vmax, and simultaneously inhibiting the Na+/Ca2+ exchanger. Enhanced Na+-K+-ATPase activity lowers the intracellular Na+, thereby minimizing Ca2+ overload and risks of arrhythmias. Inhibition of Na+/Ca2+ exchanger reduces Ca2+ efflux, thereby preserving contractility. Thus, the coordinated actions of PLM during stress serve to minimize arrhythmogenesis and maintain inotropy.
Many members of this superfamily have been characterized. FXYD5 is of 178 aas and has N-terminal (residues 7-24) and C-terminal (residues 146-162) hydrophobic regions. These proteins display a short region (130-167) with striking sequence similarity (50% identity) to established members of the PLM family. Since the region of sequence similarity includes a transmembrane domain, these auxiliary proteins may have anion-selective channel activity.
The generalized transport reaction catalyzed by PLM and Mat8 is:
Anions (out) Anions (in).
Phospholemman (PLM; FXYD1) forms anion channels and regulates L-type Ca2+ channels as well as several other cation transport systems in cardiac myocytes (Zhang et al. 2015). Palmitoylation of the mammalian Na+ pump's accessory subunit PLM by the cell surface palmitoyl acyl transferase DHHC5 leads to pump inhibition, possibly by altering the relationship between the pump's catalytic α-subunit and specifically bound membrane lipids (Howie et al. 2018). The human ortholog has UniProt acc #O00168 and is almost identical.
PLM of Canis familiaris
FXYD6 regulator of Na,K-ATPase in the ear and taste buds (95 aas; Delprat et al., 2007; Shindo et al., 2011)
FXYD6 of Homo sapiens (Q9H0Q3)
The sterol (dexamethasone, aldosterone) and low NaCl diet-inducible FXYD domain-containing ion transport regulator 4 precursor (Channel inducing factor, CHIF). It is an IsK-like MinK homologue (Attali et al., 1995). It regulates the Na+,K+-ATPase and the KCNQ1 channel protein as well as other ICNQ channels, opening them at all membrane potentials (Jespersen et al. 2006).
CHIF of Rattus norvegicus
FXYD3 (Mat-8; PLML) with two splice variants, one of 87 aas with 2 TMSs (an N-terminal leader sequence and a central very hydrophobic TMS) and the other of 116 aas and 2 TMSs (Bibert et al. 2006). Both FXYD3 variants co-immunoprecipitate with the Na,K-ATPase. They both associate stably with Na,K-ATPase isozymes but not with the H,K-ATPase or Ca-ATPase. The short human FXYD3 has 72% sequence identity with mouse FXYD3, whereas long human FXYD3 is identical to the short human FXYD3 but has a 26-amino acid insertion after the transmembrane domain. Short and long human FXYD3 RNAs and proteins are differentially expressed during differentiation with long FXYD3 being mainly expressed in nondifferentiated cells while short FXYD3 is expressed in differentiated cells (Bibert et al. 2006).
FXYD3 of Homo sapiens
FXYD4 of 89 aas and 1 TMS.
FXYD4 of Homo sapiens
FXYD7 of 80 aas and 1 TMS. The TMS mediates the complex interactions with the Na,K-ATPase (Li et al. 2005).
FXYD7 of Homo sapiens
γ-subunit (proteolipid) of Na+,K+-ATPase, FXYD2. Also functions as a cation-selective channel (Sha et al. 2008).
FXYD2 channel and γ-subunit of the Na+,K+-ATPase of Homo sapiens
FXYD5 regulator of Na,K+-ATPase and ion channel activities of 178 aas and 1 C-terminal TMS. FXYD5 interacts directly with the Na+,K+-ATPase via their TMSs to affect the Vmax of the latter, and residues involved have been identified (Lubarski et al. 2007).
FXYD5 of Homo sapiens (178 aas; Q96DB9)